565 studies found for:    Open Studies | "Ovarian Diseases"
Show Display Options
Rank Status Study
21 Recruiting Sebum Excretion in Neonates of Women With Polycystic Ovary Syndrome (PCOS)
Condition: Polycystic Ovary Syndrome
Intervention: Other: Sebutape
22 Not yet recruiting Electroacupuncture on Hormonal and Glycometabolic Profiles in Women With Polycystic Ovary Syndrome: Study Protocol
Condition: Polycystic Ovary Syndrome
Interventions: Other: Acupuncture;   Other: Placebo-acupuncture group
23 Not yet recruiting Women at Risk of Breast Cancer and OLFM4
Condition: Hereditary Breast and Ovarian Cancer Syndrome
Intervention: Biological: OLFM4
24 Recruiting Acupuncture or Metformin for Insulin Resistance in Women With PCOS
Conditions: Polycystic Ovary Syndrome;   Insulin Resistance;   Hyperandrogenism
Interventions: Other: Lifestyle management;   Device: Acupuncture;   Drug: Metformin
25 Recruiting A Comparison of Letrozole and Clomifene Citrate
Conditions: Polycystic Ovarian Syndrome;   Subfertility
Interventions: Drug: Letrozole;   Drug: Clomiphene
26 Recruiting Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
Conditions: Adult Solid Neoplasm;   Advanced Malignant Neoplasm;   Cervical Squamous Cell Carcinoma;   Recurrent Bladder Carcinoma;   Recurrent Breast Carcinoma;   Recurrent Cervical Carcinoma;   Recurrent Head and Neck Carcinoma;   Recurrent Malignant Neoplasm;   Recurrent Ovarian Carcinoma;   Recurrent Renal Cell Carcinoma;   Recurrent Uterine Corpus Carcinoma;   Sarcoma;   Stage III Bladder Cancer;   Stage III Renal Cell Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Cervical Cancer;   Stage IIIA Ovarian Cancer;   Stage IIIA Uterine Corpus Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Cervical Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIB Uterine Corpus Cancer;   Stage IIIC Breast Cancer;   Stage IIIC Ovarian Cancer;   Stage IIIC Uterine Corpus Cancer;   Stage IIIC1 Uterine Corpus Cancer;   Stage IIIC2 Uterine Corpus Cancer;   Stage IV Breast Cancer;   Stage IV Ovarian Cancer;   Stage IV Renal Cell Cancer;   Stage IVA Bladder Cancer;   Stage IVA Cervical Cancer;   Stage IVA Uterine Corpus Cancer;   Stage IVB Bladder Cancer;   Stage IVB Cervical Cancer;   Stage IVB Uterine Corpus Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Nanoparticle Albumin-Bound Rapamycin;   Other: Quality-of-Life Assessment
27 Recruiting Transplantation of HUC-MSCs With Injectable Collagen Scaffold for POF
Condition: Premature Ovarian Failure
Interventions: Biological: HUC-MSCs Transplantation;   Biological: HUC-MSCs with Injectable Collagen Scaffold Transplantation
28 Not yet recruiting Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors
Conditions: Squamous Cell Cancer of Head and Neck;   Triple Negative Breast Cancer;   Epithelial Ovarian Cancer;   Malignant Melanoma;   Advanced Solid Tumors
Intervention: Drug: Pembrolizumab
29 Recruiting Clomiphene Citrate Plus Cabergoline in Treatment of Polycystic Ovary Syndrome
Condition: Female Reproductive Problem
Interventions: Drug: Clomiphene citrate;   Drug: Cabergoline;   Other: Placebo
30 Not yet recruiting PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer
Condition: Platinum Resistant Ovarian Cancer
Interventions: Drug: Fosbretabulin tromethamine;   Drug: Placebo
31 Not yet recruiting Expression of Altered Glycosyltransferases, Mucins, and RTKs in Human Ovarian and Endometrial Cancers
Conditions: Carcinogenesis;   Ovarian Cancer;   Endometrial Cancer
Intervention:
32 Recruiting Aspiration of Limited Number of Follicles to Prevent Severe Ovarian Hyperstimulation Syndrome
Condition: Infertility
Interventions: Procedure: 7 eggs collection;   Procedure: Full eggs collection
33 Not yet recruiting DAPA, EQW, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
Conditions: Polycystic Ovary Syndrome;   Obesity
Interventions: Drug: Exenatide once weekly (EQW );   Drug: Dapagliflozin (DAPA);   Drug: EQW plus DAPA;   Drug: Dapagliflozin plus Glucophage (MET ER);   Drug: Phentermine /Topiramate (PHEN/ TRP) ER
34 Recruiting PH2 Study of IMGN853 vs Investigator's Choice of Chemo in Adults With FRa+ Adv. EOC, Primary Peritoneal or Primary Fallopian Tube Cancer
Conditions: Epithelial Ovarian Cancer;   Primary Peritoneal Carcinoma;   Primary Fallopian Tube Cancer
Interventions: Drug: IMGN853;   Drug: Paclitaxel;   Drug: Doxorubicin;   Drug: Gemcitabine;   Drug: Topotecan
35 Not yet recruiting Graceful Lifestyle Changes Study for PCOS and Infertility
Conditions: Polycystic Ovary Syndrome;   Infertility
Interventions: Behavioral: Graceful Lifestyle Changes;   Dietary Supplement: Myo-inositol;   Drug: Letrozole
36 Not yet recruiting Carboplatin and Gemcitabine Hydrochloride With or Without ATR Kinase Inhibitor VX-970 in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: High Grade Ovarian Serous Adenocarcinoma;   Ovarian Endometrioid Tumor;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Cancer;   Stage IV Primary Peritoneal Cancer
Interventions: Drug: ATR Kinase Inhibitor VX-970;   Drug: Carboplatin;   Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
37 Not yet recruiting Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple Negative Breast Cancer
Conditions: Adult Solid Neoplasm;   Estrogen Receptor Negative;   Fallopian Tube Serous Neoplasm;   HER2/Neu Negative;   Ovarian Serous Adenocarcinoma;   Ovarian Serous Tumor;   Primary Peritoneal Serous Adenocarcinoma;   Progesterone Receptor Negative;   Recurrent Breast Carcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Triple-Negative Breast Carcinoma
Interventions: Drug: Hsp90 Inhibitor AT13387;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Talazoparib
38 Recruiting The Influence of Timing of Cabergoline Initiation on Prevention of OHSS
Condition: Ovarian Hyperstimulation Syndrome
Interventions: Drug: Late Cabergoline 0.5mg;   Drug: Early Cabergoline 0.5mg
39 Recruiting Primary Ovarian Insufficiency, Polycystic Ovary Syndrome & the CardiOvascular Risk Profile
Condition: Cardiovascular Diseases
Intervention: Procedure: cardiovascular screening
40 Recruiting Urinary DENND1A.V2 as a Predictor of Pubertal Hyperandrogenemia
Conditions: Polycystic Ovary Syndrome;   Hyperandrogenism;   Puberty
Intervention: Other: Phenotype/genotype assessment

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years